New Paradigms to Fund and Manage Drug Development Conference
3:45 PM Wednesday, January 11, 2012

BayHelix 9th Annual Conference  (More...) 
Sunday, January 8, 2012
Public Sessions: 9AM - 4:45PM

Cowen’s 2012 Pacific Life Science Showcase  (More...) 
12 companies present
Monday, January 9, 5:15-6:30 PM

OneMedForum  (More...) 
China Forum II
Monday, January 9, 2012, 1PM-5PM


Discussion:

Two of the panels will feature our own Greg Scott, ChinaBio®’s CEO and Founder, and also Executive Editor of ChinaBio® Today. Greg will be moderating a panel on “Special Panel: The Life Science Investment Climate in China” at 8 am on Tuesday, January 10th. And he will also officiate on a second panel, “Opportunities for Funding and Partnering in China,” on Wednesday afternoon, January 11 at 3:45. Details on both events are listed below.

The China Track, which is part of the regular J.P Morgan proceedings, will be held on Wednesday, January 11, starting at 7:30 AM. A total of 15 companies will have a half-hour each to present their stories to investors. The lunch panel will address the issue of “The China Healthcare Marketing Environment, One Year Later.”

Events:

Opportunities for Funding and Partnering in China

New Paradigms to Fund and Manage Drug Development Conference
http://www.theconferenceforum.org/NewParadigms-Overview.html

3:45 PM Wednesday, January 11, 2012

While investment in life science continues to shrink in the U.S., China is setting new records. VC investment, IPOs and M&A activity all saw new highs in 2010, with VC investments in life science companies averaging $21M and many VC and partnering deals netting $20M to $100M and more. This session will provide information on the sources of funding in China and how western companies can access government, institutional and commercial funding.

Moderator: Greg Scott, Founder and CEO, ChinaBio, LLC

Location: Marines’ Memorial Club & Hotel
609 Sutter Street
San Francisco, CA 94102

Conference Dates: January 10-12, 2012


Special Panel: The Life Science Investment Climate in China

The Biotech Showcase
(www.ebdgroup.com/bts)

8:00 AM Tuesday, Jan. 10

While the rest of the world struggled, China is setting new records in venture capital investment, IPO and M&A activity, and partnering deals. More money was pumped into China life science companies by China government, VCs and private equity funds in 2010 than ever before. In 2011, several early stage companies have attracted more than $100M US in equity funding. Will this trend continue in 2012? This special session will focus on the funding climate in China and the potential opportunities for investors and entrepreneurs alike.

Moderator: Greg Scott

Panelists:
Leon Chen, Partner, Fidelity Growth Partners Asia
Darren Ji, Former CEO, PharmaLegacy
Kewen Jin, Managing Partner, Wen Associates
Victor Shi, President, Qiagen Asia
Steve Yang, VP & Head of R&D Asia, AstraZeneca

The Biotech Showcase will be located at:

Parc 55 Wyndham San Francisco – Union Square
55 Cyril Magnin Street
San Francisco, 94102

This Special Panel was organized by EBD Group, ChinaBio® and BayHelix.


J.P.Morgan Healthcare Conference – China Track

Wednesday, January 11, 2012
Victor’s – 32nd Floor, Tower Building, Westin St. Francis Hotel, San Francisco

Presenting Company Schedule:  (subject to change)

7:30 AM ShangPharma Corp.
8:00 AM Golden Meditech Holdings Ltd.
8:30 AM Sino Biopharmaceutical Limited
9:00 AM BeiGene Co., Ltd
9:30 AM Chindex International Inc
10:00 AM Beijing Shenogen Biomedical Co., Ltd
10:30 AM Jiangsu Hengrui Medicine Co., Ltd
11:00 AM China Kanghui Holdings Ltd
11:30 AM China Resources Healthcare Group Ltd.

12:00 PM – 1:30 PM Lunch Break

Panel Discussion: The China healthcare marketing environment,
one year later China healthcare market operating

1:30 PM 3SBio Inc.
2:00 PM Tianjin Tasly Pharmaceutical Co., Ltd.
2:30 PM Concord Medical Services Holdings Limited
3:00 PM Eddingpharm Inc.
3:30 PM Simcere Pharmaceutical Group
4:00 PM Amerigen Pharmaceuticals Ltd
4:30 PM WuXi PharmaTech


BayHelix 9th Annual Conference

Sunday, January 8, 2012
Public Sessions: 9AM - 4:45PM
BayHelix member only sessions: 4:45PM-6:00PM

Program Highlights:

Keynote Speech by Honorable California Lieutenant Governor Gavin Newsom

Panel Discussion I: Legal and Ethical Concerns for Trans-Pacific Biotech Executives

BayHelix Lifetime Achievement Award Presentation
What Are Successful Biotech Entrepreneurs Made Of ?
Kenneth Fong, PhD -- Founder of CLONTECH Laboratories; Chairman of Kenson Ventures, LLC

Panel Discussion II: Global Strategies for Chinese and Multi-National Biopharma Companies

Venue:
William J. Rutter Center
San Francisco Mission Bay
1675 Owens Street
San Francisco, California 94158


Cowen’s 2012 Pacific Life Science Showcase
AusBiotech -- A Fast, Fresh Look at Chinese and Australian Companies
1 Room, 1 Hour, 12 Companies
Monday, January 9, 2012
Time: 5:15-6:30 PM – Forum with Reception (hosted by Vivo Ventures) to follow
Venue: Sir Francis Drake Hotel, 450 Powell Street (at Sutter), San Francisco

PRESENTING COMPANIES:

AUSTRALIA
Alchemia (ASX:ACL)
Genetic Technologies (ASX:GTG)
Phylogica (ASX:PYC)
Sunshine Heart (ASX:SHC)
Uptake Medical
Viveve

CHINA
3S Bio
SciClone
Kanghui
Lee's Pharmaceutical
Simcere
Wuxi Apptec

To RSVP, please contact AusBiotech's Investment Program Manager, Hayley Laing for further information or queries hlaing@ausbiotech.org OR +613 9828 1400. Further details regarding the AusBiotech Investment Series can be found at www.ausbiotech.org/investmentseries


OneMedForum

China Forum II
Monday, January 9, 2012, 1PM-5PM
Sir Francis Drake Hotel

These sessions are designed to help senior executives shape strategy to approach what is one of the most lucrative and perilous markets in the world. The program will consist of four panel sessions that will address critical issues to understanding how Healthcare and life science companies can succeed in China.